Need a better app
Terrible app. Does not work properly. ASCO website also crushes near the board exam.
Description
ASCO-SEP® Digital Edition: 22 science and practice-based chapters written, edited, and peer-reviewed by experts across oncology specialties and disease sites.*
- Upgraded Desktop format available
- Keep track of your learning with bookmarks, notes, and a new highlighting feature
- Print PDFs of each chapter
- Choose your fonts, layouts, easy-to-read page colors, and screen brightness.
- Locate information within the text using an updated search function
* ASCO-SEP® Digital Edition and Question Bank no longer offer opportunities to claim CME credits or MOC points. The Digital Edition does not include chapter assessments. All test questions are now located in the Question Bank.
Hide
Show More...
- Upgraded Desktop format available
- Keep track of your learning with bookmarks, notes, and a new highlighting feature
- Print PDFs of each chapter
- Choose your fonts, layouts, easy-to-read page colors, and screen brightness.
- Locate information within the text using an updated search function
* ASCO-SEP® Digital Edition and Question Bank no longer offer opportunities to claim CME credits or MOC points. The Digital Edition does not include chapter assessments. All test questions are now located in the Question Bank.
Screenshots
ASCO-SEP® FAQ
-
Is ASCO-SEP® free?
Yes, ASCO-SEP® is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is ASCO-SEP® legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ASCO-SEP® cost?
ASCO-SEP® is free.
-
What is ASCO-SEP® revenue?
To get estimated revenue of ASCO-SEP® app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Italy yet.
Ratings History
ASCO-SEP® Reviews
Horrible
This app just stinks. It’s poorly designed. The text is littered with errors both in spelling, the names of diseases (Nodular lymphocyte predominant Hodgkins is a glaring example), and general design. If there were anything else out there, this wouldn’t sell. With all it costs and all we pay ASCO, we deserve better. They should be embarrassed, but I’m sure they’re not.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
ASCO-SEP® Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
HemeOncBuddy
hemeonc trials
|
View
|
View
|
0
|
|
1 year ago | |
ASTCT Practice Guidelines
|
View
|
View
|
0
|
|
5 months ago | |
Research To Practice
|
View
|
View
|
0
|
|
5 months ago | |
Cancer Pharmacology Manual
Anticancer Oncology Drug Guide
|
View
|
View
|
0
|
|
3 years ago | |
Tempus Provider
Track and view patient results
|
View
|
View
|
0
|
|
2 months ago | |
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
|
View
|
View
|
0
|
|
7 months ago | |
theMednet
Q&A from experts in medicine
|
View
|
View
|
0
|
|
8 months ago | |
ASH Pocket Guides
|
View
|
View
|
0
|
|
9 months ago | |
Hem/Onc @Point of Care
Hematology & Oncology
|
View
|
View
|
0
|
|
5 months ago | |
ALTAI Oncology
Protocols, Staging, and More
|
View
|
View
|
0
|
|
3 weeks ago |
ASCO-SEP® Installs
Last 30 days
ASCO-SEP® Revenue
Last 30 daysASCO-SEP® Revenue and Downloads
Gain valuable insights into ASCO-SEP® performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Education
- Publisher
- American Society of Clinical Oncology
- Languages
- English
- Recent release
- 1.0.4 (5 months ago )
- Released on
- Sep 14, 2023 (1 year ago )
- Also available in
- United States, Canada, Lebanon, Switzerland, Philippines, Portugal, Peru, New Zealand, Norway, Netherlands, Nigeria, Malaysia, Mexico, Kazakhstan, Kuwait, South Korea, Japan, Poland, India, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Algeria, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Chile, Colombia, Czechia, Germany, Denmark, Dominican Republic, Italy, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.